The Broad Institute's David Sabatini and colleagues report in Nature on their development and use of a method to uncover novel cancer targets. Their method uses a negative-selection RNAi screen that they then applied to find metabolic genes that are necessary for tumorigenesis in breast cancer.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.